Royal Bank Of Canada Fate Therapeutics Inc Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 14,565 shares of FATE stock, worth $13,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,565

Previous 12,171 19.67%

Holding current value

$13,254

Previous $42,000 42.86%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.61 - $3.35 $3,854 - $8,019	2,394 Added 19.67%	14,565 $24,000
Q3 2024 Nov 14, 2024	BUY	$3.12 - $5.57 $7,297 - $13,028	2,339 Added 23.79%	12,171 $42,000
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $25,538 - $55,464	7,834 Added 392.09%	9,832 $32,000
Q1 2024 Nov 05, 2024	SELL	$3.54 - $8.35 $27,732 - $65,413	-7,834 Reduced 79.68%	1,998 $14,000
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $89,172 - $210,336	-25,190 Reduced 92.65%	1,998 $14,000
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $21,172 - $50,558	12,832 Added 89.38%	27,188 $101,000
Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $7,803 - $19,469	3,863 Added 36.82%	14,356 $30,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $16,098 - $22,287	3,382 Added 47.56%	10,493 $49,000
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $67,929 - $178,153	-16,021 Reduced 69.26%	7,111 $40,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $182,972 - $442,213	18,557 Added 405.62%	23,132 $233,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $11,698 - $20,049	556 Added 13.83%	4,575 $103,000
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $127,251 - $303,385	-7,157 Reduced 64.04%	4,019 $100,000
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $467,955 - $950,736	-15,772 Reduced 58.53%	11,176 $433,000
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $778,739 - $1.05 Million	16,278 Added 152.56%	26,948 $1.58 Million
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $8.29 Million - $13.4 Million	-139,818 Reduced 92.91%	10,670 $633,000
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $10.1 Million - $13.9 Million	150,488 New	150,488 $13.1 Million

Others Institutions Holding FATE

# of Institutions

167

Shares Held

101M

Call Options Held

41.3K

Put Options Held

15.9K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $88.3M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Fate Therapeutics Inc Transaction History